_256_384.jpg)
Healthcare | June 27, 2024
Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India
Glenmark released Picture Post Cards on World Vitiligo Day
Glenmark released Picture Post Cards on World Vitiligo Day
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
EDQM has also issued a Certificate of Suitability for Allopurino
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Subscribe To Our Newsletter & Stay Updated
